1887

Abstract

and coagulase-negative staphylococci (CNS) are recognized as causing nosocomial and community-acquired infections in every region of the world. The resistance to antimicrobial agents among staphylococci is an increasing problem. Clindamycin (CL) is considered to be one of the alternative agents in these infections. This study demonstrates a simple, reliable method (double-disc diffusion test) for detecting inducible resistance to CL in erythromycin-resistance (ER-R) isolates of and CNS. A total of 883 (52.3 %) isolates of and 804 (47.7 %) isolates of CNS were selected from recent (2003–2005) clinical isolates recovered in the laboratory of the authors; duplicate isolates were not included. A total of 214 (12.6 %) and 308 (18.3 %) CNS isolates were selected based on ER-R and CL sensitivity using standard National Committee for Clinical Laboratory Standards disc diffusion testing. A total of 1687 staphylococcal isolates were included, consisting of 27.5 % meticillin-resistant , 24.8 % meticillin-sensitive , 36.1 % meticillin-resistant CNS and 11.6 % meticillin-sensitive CNS isolates: 30.9 % of staphylococcal isolates (214 and 308 CNS) that were erythromycin resistant and CL sensitive were tested for inducible resistance using the D-test. A D-shaped zone around the CL was observed for 70.9 % of staphylococcal isolates (81.8 % of isolates and 63.3 % of CNS isolates) with an ER-R and a clindamycin-sensitive (CL-S) phenotype. The organism was positive for inducible clindamycin resistance (CL-R). There was a 21.9 % level of inducible macrolide-lincosamide-streptogramin B resistance phenotype among all the staphylococcal isolates. When the and CNS strains among all the staphylococcal isolates were compared statistically, inducible CL-R in CNS strains was determined to be 23 % more positive (=0.028, odds ratio 0.77, 95 % confidence interval 0.61–0.98). When a statistical comparison was performed among ER-R but CL-S staphylococcal isolates inducible CL-R in strains was determined to be 2.6 times more positive (=0.000, odds ratio 2.6, 95 % confidence interval 1.68–4.04). A simple, reliable method of detecting inducible resistance to CL in ER-R isolates of and CNS is described. Clinical microbiology laboratories should use the double-disc diffusion test as standard practice with all ER-R staphylococci. CL should not be used in patients with infections caused by inducibly resistant staphylococcal isolates. Therapeutic failures may thus be avoided.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46761-0
2007-03-01
2019-08-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/3/342.html?itemId=/content/journal/jmm/10.1099/jmm.0.46761-0&mimeType=html&fmt=ahah

References

  1. Azap, O. K., Arslan, H., Timurkaynak, F., Yapar, G., Oruc, E. & Gagir, U. ( 2005; ). Incidence of inducible clindamycin resistance in staphylococci: first results from Turkey. Clin Microbiol Infect 11, 582–584.[CrossRef]
    [Google Scholar]
  2. Drinkovic, D., Fuller, E. R., Shore, K. P., Holland, D. J. & Ellis-Pegler, R. ( 2001; ). Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 48, 315–316.[CrossRef]
    [Google Scholar]
  3. Fiebelkorn, K. R., Crawford, S. A., McElmeel, M. L. & Jorgensen, J. H. ( 2003; ). Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 41, 4740–4744.[CrossRef]
    [Google Scholar]
  4. Fokas, S., Fokas, S., Tsironi, M., Kalkani, M. & Dionysopouloy, M. ( 2005; ). Prevalence of inducible clindamycin resistance in macrolide-resistant Staphylococcus spp. Clin Microbiol Infect 11, 337–340.[CrossRef]
    [Google Scholar]
  5. Frank, A. L., Marcinak, J. F., Mangat, P. D., Tjhio, J. T., Kelkar, S., Schreckenberger, P. C. & Quinn, J. P. ( 2002; ). Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 21, 530–534.[CrossRef]
    [Google Scholar]
  6. Goldman, R. C. & Capobianco, J. O. ( 1990; ). Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 34, 1973–1980.[CrossRef]
    [Google Scholar]
  7. Groom, A. V., Wolsey, D. H., Naimi, T. S., Smith, K., Johnson, S., Boxrud, D., Moore, K. A. & Cheek, J. E. ( 2001; ). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 286, 1201–1205.[CrossRef]
    [Google Scholar]
  8. Hussain, F. M., Boyle-Vavra, S., Bethel, C. D. & Daum, R. S. ( 2000; ). Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility. Pediatr Infect Dis J 19, 1163–1166.[CrossRef]
    [Google Scholar]
  9. Kasten, M. J. ( 1999; ). Clindamycin, metronidazole, and chloramphenicol. Mayo Clin Proc 74, 825–833.[CrossRef]
    [Google Scholar]
  10. Leclercq, R. & Courvalin, P. ( 1991a; ). Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother 35, 1267–1272.[CrossRef]
    [Google Scholar]
  11. Leclercq, R. & Courvalin, P. ( 1991b; ). Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria. Antimicrob Agents Chemother 35, 1273–1276.[CrossRef]
    [Google Scholar]
  12. McGehee, R. F., Barret, F. F. & Finland, F. ( 1969; ). Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin. Antimicrob Agents Chemother 13, 392–397.
    [Google Scholar]
  13. Naimi, T. S., LeDell, K. H., Boxrud, D. J., Groom, A. V., Steward, C. D., Johnson, S. K., Besser, J. M., O'Boyle, C., Danila, R. N. & other authors ( 2001; ). Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus: Minnesota, 1996–98. Clin Infect Dis 33, 990–996.[CrossRef]
    [Google Scholar]
  14. National Committee for Clinical Laboratory Standards ( 2003; ). Performance Standards for Antimicrobial Disk Susceptibility Tests, approved standard M2-A8. Wayne, PA: National Committee for Clinical Laboratory Standards.
  15. National Committee for Clinical Laboratory Standards ( 2004; ). Performance Standards for Antimicrobial Disk Susceptibility Testing, fourteenth informational supplement, document M100-S14. Wayne, PA: National Committee for Clinical Laboratory Standards.
  16. Panagea, S., Perry, J. D. & Gould, F. K. ( 1999; ). Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 44, 581–582.[CrossRef]
    [Google Scholar]
  17. Rao, G. G. ( 2000; ). Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci? J Antimicrob Chemother 45, 715.[CrossRef]
    [Google Scholar]
  18. Schreckenberger, P. C., Ilendo, E. & Ristow, K. L. ( 2004; ). Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 42, 2777–2779.[CrossRef]
    [Google Scholar]
  19. Siberry, G. K., Tekle, T., Carroll, K. & Dick, J. ( 2003; ). Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 37, 1257–1260.[CrossRef]
    [Google Scholar]
  20. Van der Heijden, I. M., Sinto, S., Oplustil, C. & Mendes, C. ( 2001; ). In Abstracts of the101st General Meeting of the American Society for Microbiology 2001, abstract A–86. Washington, DC: American Society for Microbiology.
  21. Van Horn, K. G. & Toth, C. ( 2003; ). In Abstracts of the 103rd General Meeting of the American Society for Microbiology 2003, abstract C–074. Washington, DC: American Society for Microbiology.
  22. Weisblum, B. & Demohn, V. ( 1969; ). Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J Bacteriol 98, 447–452.
    [Google Scholar]
  23. Werckenthin, C., Schwarz, S. & Westh, H. ( 1999; ). Structural alterations in the translational attenuator of constitutively expressed ermC genes. Antimicrob Agents Chemother 43, 1681–1685.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46761-0
Loading
/content/journal/jmm/10.1099/jmm.0.46761-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error